Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study

Cuneo A;Mato AR;Rigolin GM;Piciocchi A;Gentile M;Laurenti L;Allan JN;Pagel JM;Brander DM;Hill BT;Winter A;Lamanna N;Tam CS;Jacobs R;Lansigan F;Barr PM;Shadman M;Skarbnik AP;Pu JJ;Sehgal AR;Schuster SJ;Shah NN;Ujjani CS;Roeker L;Orlandi EM;Billio A;Trentin L;Spacek M;Marchetti M;Tedeschi A;Ilariucci F;Gaidano G;Doubek M;Farina L;Molica S;Di Raimondo F;Coscia M;Mauro FR;de la Serna J;Medina Perez A;Ferrarini I;Cimino G;Cavallari M;Cucci R;Vignetti M;Foà R;Ghia P;GIMEMA;European Research Initiative (ERIC) on CLL;US study group.

2020-01-01